Tirbanibulin: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 April 2025

  • curprev 17:0517:05, 27 April 2025 Alara E. Dagsali talk contribs 15,403 bytes +15,403 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=tirbanibulin |aOrAn=a |drugClass=non-ATP competitive Src kinase inhibitor and tubulin polymerization inhibitor. |indicationType=treatment |indication=of actinic keratosis on the face or scalp |adverseReactions=*Application site pruritus *Application site paina |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">..."